| Literature DB >> 35702492 |
Rita K Schmutzler1, Björn Schmitz-Luhn2, Bettina Borisch3, Peter Devilee4, Diana Eccles5, Per Hall6, Judith Balmaña7, Stefania Boccia8,9, Peter Dabrock10, Günter Emons11, Wolfgang Gaissmaier12, Jacek Gronwald13, Stefanie Houwaart14, Stefan Huster15, Karin Kast1, Alexander Katalinic16, Sabine C Linn17, Sowmiya Moorthie18, Paul Pharoah19, Kerstin Rhiem1, Tade Spranger20, Dominique Stoppa-Lyonnet21, Johannes Jozef Marten van Delden22, Marc van den Bulcke23, Christiane Woopen2.
Abstract
Background: Risk-adjusted cancer screening and prevention is a promising and continuously emerging option for improving cancer prevention. It is driven by increasing knowledge of risk factors and the ability to determine them for individual risk prediction. However, there is a knowledge gap between evidence of increased risk and evidence of the effectiveness and efficiency of clinical preventive interventions based on increased risk. This gap is, in particular, aggravated by the extensive availability of genetic risk factor diagnostics, since the question of appropriate preventive measures immediately arises when an increased risk is identified. However, collecting proof of effective preventive measures, ideally by prospective randomized preventive studies, typically requires very long periods of time, while the knowledge about an increased risk immediately creates a high demand for action. Summary: Therefore, we propose a risk-adjusted prevention concept that is based on the best current evidence making needed and appropriate preventive measures available, and which is constantly evaluated through outcome evaluation, and continuously improved based on these results. We further discuss the structural and procedural requirements as well as legal and socioeconomical aspects relevant for the implementation of this concept.Entities:
Keywords: Breast cancer; ELSI ethical, legal, social implications; Evidence-generating care; Risk-adjusted prevention
Year: 2021 PMID: 35702492 PMCID: PMC9149472 DOI: 10.1159/000517182
Source DB: PubMed Journal: Breast Care (Basel) ISSN: 1661-3791 Impact factor: 2.268